Click a link below to view the mailing archive as if it had been sent to you.
| 2021-07-31 00:15 | | Six more biotechs price public debuts just before the start of the weekend and more... |
| 2021-07-30 12:15 | | Vertex Hopes to Channel CF Drug Successes into Other Therapies in the Pipeline and more... |
| 2021-07-30 00:15 | | Israeli Health Ministry approves covid booster shot for older population and more... |
| 2021-07-29 12:15 | | FDA approves first interchangeable biosimilar and more... |
| 2021-07-29 00:15 | | More brand-name drug prices hiked this year than in all of 2020, study finds and more... |
| 2021-07-28 12:15 | | AstraZeneca Shot Brings No Increased Blood-Clot Risk After Two Doses and more... |
| 2021-07-28 00:15 | | Merck rebounds to win a milestone immunotherapy approval in early breast cancer and more... |
| 2021-07-27 12:15 | | Purdue Pharma’s Creditors Vote Yes To Bankruptcy Deal Shielding Billionaire Owners From Future Opioid Lawsuits and more... |
| 2021-07-27 00:15 | | As GlaxoSmithKline works to get Shingrix back on track, an FDA approval increases the key vaccine's reach and more... |
| 2021-07-26 12:15 | | Another one bites the dust: Bristol Myers Squibb pulls 'dangling' accelerated approval for Opdivo in liver cancer and more... |
| 2021-07-25 12:15 | | AI breakthrough could spark medical revolution and more... |
| 2021-07-25 00:15 | | FDA Greenlights AbbVie’s Antibiotic Dalvance for Acute Skin Infections in Children and more... |
| 2021-07-24 00:15 | | Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant |
| 2021-07-23 12:15 | | Study finds vaccines cut severe variant COVID disease after one shot and more... |
| 2021-07-23 00:15 | | Fight over “pay for delay” heats up in Washington and more... |
| 2021-07-22 12:15 | | Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table and more... |
| 2021-07-22 00:15 | | Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study and more... |
| 2021-07-21 12:15 | | Johnson & Johnson Q2 Earnings Beat Expectations; Raises FY21 Outlook, Sees $2.5B Sales From COVID Vaccine and more... |
| 2021-07-21 00:15 | | EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine and more... |
| 2021-07-20 12:15 | | FDA gives speedy review to Bayer’s Parkinson’s stem cell therapy and more... |
| 2021-07-20 00:15 | | What happened to Novavax's COVID-19 vaccine candidate? and more... |
| 2021-07-19 12:15 | | FDA’s domestic biopharma inspections return to normal as agency faces backlog of 8,000+ and more... |
| 2021-07-19 00:15 | | 10 of the Most Controversial Deals in Medtech and more... |
| 2021-07-16 12:15 | | Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit and more... |
| 2021-07-16 00:15 | | Ipsen bets up to $363M on another shot at a debilitating condition related to Parkinson's disease and more... |
| 2021-07-15 12:15 | | Narcan Creator Takes on Synthetic Opioid Overdoses with Experimental Nasal Spray and more... |
| 2021-07-15 00:15 | | U.S. health official says COVID-19 boosters could risk more serious side effects and more... |
| 2021-07-14 12:15 | | Private insurers decline to cover Biogen's new Alzheimer's drug in escalating standoff — report and more... |
| 2021-07-14 00:15 | | So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds and more... |
| 2021-07-13 12:15 | | FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat and more... |
| 2021-07-13 00:15 | | J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says and more... |
| 2021-07-12 12:15 | | The top 15 blockbuster patent expirations coming this decade and more... |
| 2021-07-12 00:15 | | Pfizer to discuss vaccine booster with U.S. officials Monday and more... |
| 2021-07-10 12:15 | | FDA Head Calls for Inspector General Investigation of Aduhelm Approval and more... |
| 2021-07-10 00:15 | | Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients |
| 2021-07-09 12:15 | | Biden to direct moves on drug importation, call for plan to lower drug prices and more... |
| 2021-07-09 00:15 | | Merck partners with Innervia on bioelectronic therapy development and more... |
| 2021-07-08 12:15 | | FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment and more... |
| 2021-07-08 00:15 | | 'Data mining' and 'p-value hacking': Cel-Sci CEO tries to spin cancer trial failure into a win and more... |
| 2021-07-07 12:15 | | Pfizer victory in Vyndaqel copay lawsuit could kneecap the government's only control on prices, lawyer warns and more... |
| 2021-07-07 00:15 | | More than 99% of people who died from COVID-19 in June were not vaccinated and more... |
| 2021-07-06 12:15 | | Novartis to make Leqvio for U.S. in Austria to overcome FDA delay and more... |
| 2021-07-06 00:15 | | How Pfizer, Moderna & J&J are testing their vaccines in children and more... |
| 2021-07-02 12:15 | | GSK backs CEO Walmsley, rejecting Elliott’s call to change board and more... |
| 2021-07-02 00:15 | | Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer and more... |
| 2021-07-01 12:15 | | CureVac to ‘plow forward’ with Covid vaccine despite disappointing results and more... |
| 2021-07-01 00:15 | | Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug and more... |
